alexionpharma.ca
Alexion | Official Canada WebsiteAlexion is dedicated to developing and delivering life-transforming therapies for patients with severe and life-threatening diseases. Find local company information.
http://www.alexionpharma.ca/
Alexion is dedicated to developing and delivering life-transforming therapies for patients with severe and life-threatening diseases. Find local company information.
http://www.alexionpharma.ca/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
0.8 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
5
SITE IP
52.85.77.190
LOAD TIME
0.758 sec
SCORE
6.2
Alexion | Official Canada Website | alexionpharma.ca Reviews
https://alexionpharma.ca
Alexion is dedicated to developing and delivering life-transforming therapies for patients with severe and life-threatening diseases. Find local company information.
Atypical Haemolytic Uremic Syndrome (aHUS)
http://www.alexionpharma.ca/patients/atypical-haemolytic-uremic-syndrome
Patient Groups and Resources. Soliris in atypical HUS. Raquo; atypical HUS. Atypical haemolytic uremic syndrome (atypical HUS) is an ultra-rare, potentially life-threatening, genetic disease that leads to the formation of blood clots in small blood vessels throughout the body. These blood clots can lead to stroke, heart attack, kidney failure and death. Atypical HUS is caused by a permanent genetic mutation that leads to uncontrolled and excessive activation of complement. One of the most common signs of...
Focus on Patients with Ultra-rare Diseases
http://www.alexionpharma.ca/patients
Patient Groups and Resources. Soliris in atypical HUS. Many patients and families faced with the challenges of a rare or ultra-rare disease live with little hope, have limited or no treatment options, and face a shortened life-span. Every day, we strive to make a life-transforming impact on the lives of patients with severe and life-threatening rare disorders. Diagnosed with PNH at 24 years old. Diagnosed with aHUS at 22 years old. Diagnosed with HPP at 2 weeks old. Patient Groups and Resources.
Information About Ultra-Rare Diseases | Alexion
http://www.alexionpharma.ca/patients/ultra-rare-diseases
Patient Groups and Resources. Soliris in atypical HUS. Raquo; Ultra-Rare Diseases. Rare and Ultra-rare Diseases. Rare and ultra-rare diseases affect very small numbers of patients. In Canada, a rare disease is defined as one that affects about 500 in a million Canadians. The European Commission defines a rare disease as one that affects fewer than five people per 10,000 of the population,. And an ultra-rare disease as one that affects less than one person per 50,000 people. Alexion has a proven track rec...
Resources and Support for Patients with Ultra-rare Diseases
http://www.alexionpharma.ca/patients/resources-and-groups
Patient Groups and Resources. Soliris in atypical HUS. Raquo; Patient Groups and Resources. Patient Groups and Resources. Alexion shares key goals with patient organizations worldwide, including increasing the understanding of rare and ultra-rare diseases, improving patient care, and enhancing patient access to innovative therapies. Our approach to serving patients is driven by a passion for understanding and meeting the unique needs of patients and families suffering from rare diseases.
Information About Alexion for Healthcare Professionals
http://www.alexionpharma.ca/healthcare-professionals/Strensiq-in-HPP
Patient Groups and Resources. Soliris in atypical HUS. Raquo; Strensiq in HPP. HPP is a life-threatening, systemic, inherited metabolic disorder caused by loss-of-function mutations in the ALPL gene, resulting in a deficiency of the alkaline phosphatase (ALP) enzyme. This deficiency leads to debilitating or life-threatening consequences. Regardless of age, patients with HPP face a range of devastating skeletal and other systemic consequences. A widely available, routine blood test can detect low ALP.
TOTAL PAGES IN THIS WEBSITE
20
Alexion Pharmaceuticals Global Presence
http://www.alexionpharma.eu/About/Global-Presence.aspx
This website requires cookies to provide all of its features and uses tracking technologies. For more information on what data is contained in the cookies and which technologies are used, please see our Privacy Policy. And Cookie and Site Usage Tracking Policy. If you continue to use this site we will assume that you agree to our terms. Europe, the Middle East and Africa. Sponsored Research and Collaborations. EMEA Headquarters, Switzerland. Global Supply Chain Operations, Ireland. Raquo; Global Presence.
Alexion Pharmaceuticals in Canada | Location Information
http://alexion.com/SelectCountry/Canada.aspx
Europe, the Middle East and Africa. Corporate Giving and Support. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Alexion has operations in Canada to serve patients locally. Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare disorders. Learn more about Alexion in Canada. Please see Full Prescribing Information. And Important Safety Information. Residents of the United States.
2016 CAPHC Annual Conference
http://www.caphcevents.org/conf2016/sponsorship/&lang=en
CAPHC gratefully recognizes the 2016 CAPHC Annual Conference Sponsors. The support provided by these organizations helps contribute to the success of our annual event. For more information, click here to download the full Corporate Invitation and Commitment Form! About the CAPHC Conference.
Vendor Sessions | MGCC
http://www.mgcc2016.com/vendor-sessions
Schedule at a Glance. Abstract Notifications CSCC: April 15, 2016. Early Registration Discount: April 30, 2016. Ammonia scavengers for Urea Cycle Disorder therapy. Skeletal Dysplasias: Identification of New Genes and Development of New Therapies. Laboratory Test Utilization-Opportunities, Strategies and leading change. Natriuretic Peptides in diagnosis and therapeutic decision making in heart failure. Advances in QC: A New, Robust Approach to Patient QC and Selecting Optimal Control Rules for PT/QC.
Sponsorship | MGCC
http://www.mgcc2016.com/sponsorship
Schedule at a Glance. Abstract Notifications CSCC: April 15, 2016. Early Registration Discount: April 30, 2016. Download the Sponsorship Prospectus. Entitlements All Platinum level entitlements PLUS:. Corporate logo on delegate conference receipts. First opportunity for the Breakfast Seminars and Industry Workshops (application must be received by Feb. 29, 2016). 1 Additional Exhibitor Name Tags (4 Total). 1 Additional Opening Reception Tickets (4 Total). 1 Additional Banquet Tickets (4 Total). 1 Additio...
TOTAL LINKS TO THIS WEBSITE
5
Noaptea Bibliotecilor
Http:/ www.noapteabibliotecilor.ro/. Noaptea Bibliotecilor 1-2 octombrie. Bucuresti, Berceni, Romania. View my complete profile. Tuesday, 20 September 2011. Intra pe http:/ www.noapteabibliotecilor.ro/ pentru ultimele informatii si detalii. Simplu. De ce sunt 4 sucuri,cand ei sunt doar 3? Thursday, 23 June 2011. Umorul-rafala de inteligenta" - Jacques Seguela,in carte "Un fiu al publicitatii". Monday, 6 June 2011. Incercarea de a explica tot mai complicat activitatea umana. Friday, 20 May 2011.
My Site
This is my site description. Powered by InstantPage® from GoDaddy.com. Want one?
The Voice Of Alexione
The Voice Of Alexione. New Lightwave with CORE technology. Announced they plan to release new version of Lightwave 3D. Which will use parts of their new CORE technology. This new version is called Lightwave HC, and will serve as transition from "old" Lightwave to the new Lightwave with CORE. For user inteface, Python. For scripting, Bullet. Physics library, integration with OpenFX. You can read more about Lightwave 3D with CORE technology in official newsletter. BTW, do you know what is Eipix Store.
Création de site internet et référencement web à Rennes
Contactez-moi au 06 75 15 20 04. CRÉATION DE SITE INTERNET ET RÉFÉRENCEMENT WEB À RENNES. Contactez-moi au 06 75 15 20 04 ou à. DEVIS GRATUIT ET PERSONNALISÉ EN 48H. La conception de votre site internet est l’une des étapes les plus importantes dans votre communication online. Je réalise votre site internet optimisé pour les supports mobiles. Votre site web est optimisé dès sa construction afin qu’il puisse être naturellement bien indexé et positionné sur les moteurs de recherche comme Google. Spa de la ...
Alexion Pharmaceuticals (NASDAQ:ALXN) | Official Corporate Site
Europe, the Middle East and Africa. Sponsored Research and Collaborations. Alexion to Acquire Synageva. For more information click here. No is a word they’ve. Most patients with severe and life-threatening rare diseases live with no effective treatment options and no hope. We develop and deliver treatments that will dramatically transform their lives. No is a word they’ve. No is a word they’ve. Read the Letter to Our Shareholders from Alexions 2014 Annual Report. Our development pipeline is focused on hi...
Alexion | Official Canada Website
Patient Groups and Resources. Soliris in atypical HUS. Ldquo;No” is a word they’ve heard too often. Alexion is a global biopharmaceutical company focused on serving patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to develop and deliver therapies that will dramatically transform their lives. In Canada, Soliris. We are currently conducting clinical tr...
Alexion Pharmaceuticals (NASDAQ:ALXN) | Official Corporate Site
Europe, the Middle East and Africa. Sponsored Research and Collaborations. Alexion to Acquire Synageva. For more information click here. No is a word they’ve. Most patients with severe and life-threatening rare diseases live with no effective treatment options and no hope. We develop and deliver treatments that will dramatically transform their lives. No is a word they’ve. No is a word they’ve. Read the Letter to Our Shareholders from Alexions 2014 Annual Report. Our development pipeline is focused on hi...
Alexion | Official Australia Website
Patient Groups and Resources. Why Choose Alexion Australia. Ldquo;No” is a word they’ve heard too often. Alexion is a global biopharmaceutical company focused on serving patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to develop and deliver therapies that will dramatically transform their lives. In Australia, Soliris. David Kwasha, Managing Director.
Alexion | Official Brazil Website
Web Corporativa de Alexion. Doenças Raras e Ultrarraras. Profissionais da Saúde (área restrita). Por que a Alexion? Nossa meta é disponibilizar inovações médicas onde elas ainda não existem. Em apoio ao Dia Internacional das Doenças Raras de 2015, a Alexion alia-se a associações de pacientes ao redor do mundo. Alexion Brasil (Morumbi Corporate Towers). Avenida Dr. Chucri Zaidan, 1.240 - 18º andar - Cj 1801 - Torre A - Golden Tower. Bairro Vila São Francisco - CEP: 04711-130 - São Paulo - SP - Brasil.
Alexion | Mapa de la Web oficial de España
Web Corporativa de Alexion. Centrados en el paciente. Enfermedades raras y ultra-raras. Hemoglobinuria Paroxística Nocturna (HPN). Síndrome Hemolítico Urémico atípico (SHUa). Grupos de pacientes y recursos. Soliris en la HPN. Soliris en el SHUa. Por qué elegir Alexion Pharma Spain. Consultas de los medios de comunicación. No es una palabra que los pacientes han escuchado con demasiada frecuencia. Para obtener más información sobre empleo en Alexion Pharma Spain. El 23 de septiembre de 2016, más de 1....
Alexion Pharmaceuticals | Official EU Website
This site uses cookies to give you the best experience on our website. By continuing to browse this site, you give consent for cookies to be used. For more details please read our Privacy Information. Europe, the Middle East and Africa. Sponsored Research and Collaborations. EMEA Headquarters, Switzerland. Global Supply Chain Operations, Ireland. Alexion R&D Center, France. Ldquo;No” is a word they’ve heard too often. Mdash; Carsten Thiel, Ph.D. Senior Vice President, EMEA and Asia Pacific. Avenue du Tri...